National Kidney Foundation of Hawaii
Honolulu, Hawaii, 96822-2214, United States
Location contact
Ann Hataoka, VP of Finance and Operations
CONTACT
Kamomilani A. Wong, PhD, MS
CONTACT
Kamomilani A. Wong, PhD, MS
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06843603
Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research. This project's outcome is to improve kidney disease follow-up among early stage NHs at high risk by aligning health equity with a culturally appropriate care coordination systems model.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Honolulu, Hawaii, 96822-2214, United States
Ann Hataoka, VP of Finance and Operations
CONTACT
Kamomilani A. Wong, PhD, MS
CONTACT
Kamomilani A. Wong, PhD, MS
PRINCIPAL_INVESTIGATOR
SPECIFIC AIMS Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant as compared to those who identify race as White. NH have the highest rates of end-stage kidney disease in the United States (US) and begin dialysis at younger ages (30-50 years). NHs are also at high risk for diabetes, hypertension, cardiovascular disease, stroke, & obesity which intersects with kidney disease. NHs are also one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research.4 Therefore, there is a is critical need to examine and address kidney health disparities and inequities in the NH population.
This multi-disciplinary scientific team has conducted cross-sectional epidemiological early CKD studies over a 10-year period of time among NHs who participated in the National Kidney Foundation of Hawaii (NKFH) Kidney Early Detection & Screening (KEDS) Program. Our findings indicate NHs have a heightened risk of end stage kidney disease based on biological and clinical risk factors5 using CKD biomarkers (i.e. lab tests for estimated glomerular filtration rate (eGFR↓) and urinary albumin creatinine ratio (UACR↑). These tests are indicators of abnormal kidney function and damage. One of the US Healthy People 2030 goals is to increase the proportion of older adults with CKD to obtain recommended screening tests (eGFR, UACR) to identify CKD in the early stages. The NKFH KEDS program provides a comprehensive community early detection screening program where participants are sent their screening lab results and are asked to share these results with their primary care provider (PCP). Our previous research has highlighted significant gaps related to participant follow-up with their PCP. Therefore, using the NIMHD Framework adapted to reflect social and cultural influences of NH health focused on family and community support/resources, access to cultural institutions and practice, and access to services to optimal health and well-being, the overall goal of this study is to develop a culturally-informed care coordination model between NKFH KEDS NH participants and NKFH and PCP staff to improve screening follow-up. Our central hypothesis is that a theoretically-driven, culturally-informed, care coordination model will not improve follow-up for eGFR & UACR. To address this gap, this innovative study aims to adapt the abridged version of the Consolidated Framework for Implementation Research 2.0 framework named pragmatic context assessment tool (pCAT) for screening (eGFR, UACR) follow-up among NH adults in early stages of CKD. Specific Aims include:
Aim 1: Understand barriers and facilitators associated with culturally informed care coordination and follow-up for eGFR & UACR. First, we will conduct a formative evaluation on the barriers & facilitators of NKFH KEDS NH participants (n=25) and NKFH (n=15) and PCP (n=10) staff) and reach consensus by all (NH participants, NKFH and PCP staff, and a NH advisory group) of a feasible intervention - (1) NKFH KEDS NH participants, using the pCAT survey and interview and (2) NKFH and PCP staff, using the same pCAT18 survey and interview. NH participants (n=25) will be: (1) aged 18 years and older, (2) with eGFR < 60 ml/min/1.73m2 (Stage 3a-3b CKD) and/or ≥30 UACR, (3) have participated in the NKFH KEDS Program within 3 months, and (4) able to read, write, and speak English. NKFH (n=15) and PCP (n=10) staff's inclusion criteria include: (1) able to read, write & speak English and (2) aged 18 years and older. Three PCP sites will be selected due to high enrollment of NH patients in their practice. Consensus of key barriers/facilitators and contextual factors that will drive the intervention selection will be completed based on the evaluation results. The research team will summarize the literature on the implementation strategies, suggest strategies and reach consensus for a selected intervention by the end of study year 1. The advisory group will be made up of members from 3 NH non-profit organizations. Quantitative and qualitative analysis for the evaluation will be completed.
Aim 2: Examine the acceptability and feasibility of a culturally-informed care coordination intervention. Second, we will evaluate our intervention by selecting one PCP site to receive usual care and other PCP site will receive the culturally informed care coordination intervention. The NKFH KEDS NH participants (n=25) and NKFH (n=5) and PCP (n=5) staff (for each, control and intervention group) will be interviewed using the pCAT18 individual survey and interview evaluation and outcomes20 of our intervention in the first 6 months of study year 2. Finally, both quantitative and qualitative analysis will be used to examine the acceptability and feasibility of the intervention in the second half of year 2.
The long-term goal of this project is to improve CKD rescreening among early stage high-risk NHs by aligning health equity with a culturally appropriate care coordination systems model. To reach this goal, results from this NIH R21 project will provide the foundation for a pilot study for an NIH R34 IRINAH. This project has the potential for dissemination to other primary care provider offices and organizations - federally qualified community centers, and hospital clinics to increase re-screening rates among high risk NHs in the early stages of CKD between community and primary care provider follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
AIM 1 and AIM 2: Inclusion Criteria: Native Hawaiian (NH) participants from the NKFH KEDS program are:
AIM 1 and AIM 2: Inclusion Criteria: NKFH and PCP staff are :
Exclusion criteria
None
Culturally Informed Care Coordination Strategies
No Intervention - Usual Care Group
Time frame: 9 months
Acceptability (the degree to which an intervention is perceived a good fit)
Acceptability will be measured by a survey likert scale of 1 (not acceptable) - 10 (most acceptable)
Name of measurement tool is reference in Procter et al (p. 69):
Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.
Time frame: 9 months
Adoption (intent to implement)
Adoption will be scored as 0 (not at all implemented), 5 (somewhat implemented), and 10 (fully implemented).
Name of measurement tool is reference in Procter et al (p. 69):
Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.
Time frame: 9 months
Feasibility (possibility of successful implementation),
Feasibility will be measured by a survey likert scale of 1 (not feasible) - 10 (most feasible).
Name of measurement tool is reference in Procter et al (p. 69):
Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.
Time frame: 9 months
TOTAL SCORE of 4 Questions will measure the secondary outcome measure - Beliefs to Change.
Believe that rescreening for eGFR & UACR can directly influence your health Believe that integrating eGFR and UACR are worthwhile use of health care services Believe that primary care providers are committed to supporting rescreening for eGFR & UACR Believe that rescreening for eGFR and UACR belong in primary care health services.
Asked to complete a survey with a 10-point Likert scale (0=Strongly Disagree to 10=Strongly Agree). Scores will be added to obtain a Total Score to measure the secondary outcome measure - Beliefs to Change.
Contact information is provided by the study sponsor or research team.
Kamomilani A. Wong, PhD, MS
CONTACT
Merle R. Kataoka-Yahiro, DrPH, MPH, MS
CONTACT
University of Hawaii
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718568
Chronic Disease, Disease Attributes
Marseille, France
View Trial DetailsNCT06182475
Chronic Disease, Disease Attributes
Livingston, New Jersey, United States
View Trial DetailsNCT07471802
Cardio-Renal Syndrome, Cardiorenal Syndrome
View Trial DetailsNCT07240987
Chronic Disease, Diabetes Complications
View Trial Details